Cetaphil Acne Relief Body Wash

Description

Cetaphil® Acne Relief Body Wash is a maximum strength over-the-counter (OTC) formulation designed to effectively eliminate breakouts. This product provides 24-hour dryness relief and incorporates an advanced moisture blend to maintain skin hydration. The active ingredient, 2% salicylic acid, serves as an acne treatment. The body wash is available in a 20 fluid ounce (591 mL) container.

Uses and Indications

This drug is indicated for the management of acne in individuals with acne-prone skin. It is formulated as a maximum strength over-the-counter (OTC) treatment designed to eliminate breakouts effectively. The formulation provides 24-hour dryness relief and contains 2% Salicylic Acid, which serves as an active ingredient for acne treatment.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to dampened skin, ensuring that it is gently massaged into the area of application. Following the massage, the product must be rinsed thoroughly with warm water. After rinsing, the skin should be patted dry with a clean towel.

In the event that bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to minimize these side effects.

Contraindications

There are no specified contraindications for this product. However, it is advised to discontinue use and consult a healthcare professional if severe irritation occurs. Additionally, the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. Therefore, it is recommended to use only one topical acne medication at a time to minimize the risk of adverse effects.

Warnings and Precautions

For external use only. This product is not intended for ingestion. In the event of accidental swallowing, it is imperative to seek immediate medical assistance or contact a Poison Control Center.

Healthcare professionals should advise patients to discontinue use and consult a physician if severe irritation occurs. Monitoring for signs of irritation is essential to ensure patient safety and to determine the need for further medical evaluation.

Side Effects

Patients should be aware that the product is intended for external use only. In the event that irritation becomes severe, it is advised to stop use and consult a healthcare professional.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Cetaphil Acne Relief Body Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may also be beneficial in guiding the management of the overdose.

Documentation of the incident, including the substance involved, the amount ingested, and the time of ingestion, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to understand the potential risks associated with accidental ingestion.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience severe irritation. This guidance is crucial to ensure patient safety and to prevent further complications.

Additionally, healthcare providers should inform patients that the likelihood of skin irritation and dryness may increase if they are using another topical acne medication concurrently. Patients should be encouraged to use only one topical acne medication at a time to minimize the risk of irritation and to achieve optimal treatment outcomes.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat. Additionally, it is essential to keep the product out of reach of children. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cetaphil Acne Relief Body Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)